UroGen Pharma Ltd. Ordinary Shares Share Price
NASDAQ: URGNHealthcare
Live UroGen Pharma Ltd. Ordinary Shares Share Price Chart
O H L
UroGen Pharma Ltd. Ordinary Shares Performance Overview
Days Range
▼
$43.25Low
$43.58High
Markets Today
| Previous Close | $43.95 |
|---|---|
| Open | $43.25 |
| Volume | 73,344 |
| Day's Range | $43.25 - $43.58 |
| 52W Range | $15.86 - $50.81 |
| Market Cap | $2.13 B |
Historical Performance
| 1M Returns | -10.16 |
|---|---|
| 3M Returns | +30.92 |
| 6M Returns | +137.82 |
| 1Y Returns | +132.91 |
| 5Y Returns | +163.49 |
| 10Y Returns | NA |
UroGen Pharma Ltd. Ordinary Shares Fundamentals
| Market Cap | $2.13 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $109.79 M |
| ROE TTM | N/A |
| EPS TTM | $-1.98 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-124.56 M |
| Profit Margin | -139.81 |
| Market Cap | $2.13 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $109.79 M |
| ROE TTM | N/A |
| EPS TTM | $-1.98 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-124.56 M |
| Profit Margin | -139.81 |
UroGen Pharma Ltd. Ordinary Shares Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $20.25 M | $24.21 M | $27.48 M | $37.84 M | $50.96 M | $72.46 M |
| Gross Profit + | $17.92 M | $20.66 M | $24.20 M | $34.55 M | $46.82 M | $65.88 M |
| Operating Income | -$36.91 M | -$41.45 M | -$27.39 M | -$19.11 M | -$20.26 M | $111.00 K |
| EBITDA | -$36.84 M | -$41.37 M | -$27.31 M | -$19.04 M | -$20.19 M | $189.00 K |
| Interest Expense | -$4.07 M | -$4.13 M | -$3.37 M | -$3.77 M | -$4.18 M | -$4.89 M |
| Depreciation | $72.00 K | $80.00 K | $80.00 K | $75.00 K | $75.00 K | $78.00 K |
| Income Before Tax | -$43.45 M | -$48.92 M | -$34.40 M | -$26.64 M | -$28.35 M | -$8.72 M |
| Income Tax Expense | $392.00 K | $1.01 M | -$1.05 M | -$275.00 K | -$4.77 M | $5.63 M |
| Net Income + | -$43.84 M | -$49.94 M | -$33.35 M | -$26.36 M | -$23.57 M | -$14.35 M |
| Net Profit Margin | -216.47% | -206.24% | -121.34% | -69.68% | -46.26% | -19.81% |
UroGen Pharma Ltd. Ordinary Shares Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $126.00 K | $126.00 K | $128.00 K | $133.00 K | $134.00 K | $135.00 K |
| Reserve & Surplus | -$850.05 M | -$900.00 M | -$933.33 M | -$959.70 M | -$983.28 M | -$997.64 M |
| Non-Current Liabilities | $252.08 M | $254.54 M | $258.21 M | $259.51 M | $327.31 M | $323.07 M |
| Current Liabilities | $42.00 M | $47.55 M | $42.24 M | $46.42 M | $50.63 M | $61.91 M |
| Total Liabilities | $294.08 M | $302.09 M | $300.45 M | $305.93 M | $377.94 M | $384.99 M |
| Fixed Assets | $627.00 K | $688.00 K | $695.00 K | $637.00 K | $616.00 K | $597.00 K |
| Current Assets | $237.18 M | $196.87 M | $168.55 M | $186.02 M | $237.46 M | $235.43 M |
| Total Assets | $247.62 M | $208.72 M | $185.05 M | $200.46 M | $253.69 M | $252.59 M |
UroGen Pharma Ltd. Ordinary Shares Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$43.84 M | -$49.94 M | -$33.35 M | -$26.36 M | -$23.57 M | -$14.35 M |
| Operating Cash Flow | -$42.02 M | -$39.83 M | -$42.27 M | -$38.33 M | -$45.32 M | -$33.01 M |
| Investing Cash Flow | -$25.96 M | $28.41 M | $31.40 M | $27.72 M | -$20.69 M | $1.67 M |
| Financing Cash Flow | $34.00 K | $296.00 K | $8.27 M | $31.32 M | $65.20 M | $500.00 K |
| Change in Cash | -$67.95 M | -$11.12 M | -$2.60 M | $20.71 M | -$800.00 K | -$30.83 M |
UroGen Pharma Ltd. Ordinary Shares Return Calculator
The UroGen Pharma Ltd. Ordinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$26,157
Invested Amount$10,000
Est. Returns$16,157
About UroGen Pharma Ltd. Ordinary Shares
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.
Popular Stocks
FAQs
What is the share price of UroGen Pharma Ltd. Ordinary Shares today?
UroGen Pharma Ltd. Ordinary Shares (URGN) share price as of September 18, 2026 is $43.63. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of UroGen Pharma Ltd. Ordinary Shares?
Yes, Indian Investors can invest in the UroGen Pharma Ltd. Ordinary Shares (URGN) Share by opening an international trading account with Angel One.
How can I purchase UroGen Pharma Ltd. Ordinary Shares shares in India?
Purchasing UroGen Pharma Ltd. Ordinary Shares (URGN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying UroGen Pharma Ltd. Ordinary Shares (URGN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of UroGen Pharma Ltd. Ordinary Shares?
Yes, you can purchase fractional shares of UroGen Pharma Ltd. Ordinary Shares (URGN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of UroGen Pharma Ltd. Ordinary Shares?
The market capitalization of UroGen Pharma Ltd. Ordinary Shares on September 18, 2026, is $2.13 B.
In which sector UroGen Pharma Ltd. Ordinary Shares belongs?
UroGen Pharma Ltd. Ordinary Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in UroGen Pharma Ltd. Ordinary Shares stocks?
In order to invest in UroGen Pharma Ltd. Ordinary Shares (URGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
